Comment to Sands et al. — No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
Author(s) -
Van Thuan Hoang
Publication year - 2021
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2021.02.079
Subject(s) - hydroxychloroquine , covid-19 , medicine , scopus , mortality rate , pediatrics , disease , medline , virology , infectious disease (medical specialty) , outbreak , law , political science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom